Hebebrand, J., Milos, G., Wabitsch, M., Teufel, M., Führer, D., Bühlmeier, J., … Antel, J. Clinical Trials Required to Assess Potential Benefits and Side Effects of Treatment of Patients With Anorexia Nervosa With Recombinant Human Leptin. Frontiers in Psychology, 10, 769. https://doi.org/10.3389/fpsyg.2019.00769 (Original work published 2019)

Hebebrand, J., Antel, J., Tan, S., Wabitsch, M., Wiesing, U., Barth, N., … Hinney, A. (2021). Kurzzeitige Behandlung von Patient_innen mit Anorexia nervosa mit rekombinant hergestelltem Human-Leptin (Metreleptin): Rasch einsetzende positive Effekte auf Stimmung, Kognition und Verhalten. Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie, 49(1), 1-5. https://doi.org/10.1024/1422-4917/a000775

Antel, J., Tan, S., Grabler, M., Ludwig, C., Lohkemper, D., Brandenburg, T., … Hebebrand, J. (2021). Rapid amelioration of anorexia nervosa in a male adolescent during metreleptin treatment including recovery from hypogonadotropic hypogonadism. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-021-01778-7 (Original work published 2021)

Bühlmeier, J., Frölich, S., Ludwig, C., Knoll-Pientka, N., Schmidt, B., Föcker, M., & Libuda, L. (2022). Changes in patterns of eating habits and food intake during the first German COVID-19 lockdown: results of a cross-sectional online survey. European Journal of Nutrition, 61(6), 3293-3306. https://doi.org/10.1007/s00394-022-02919-7